What is the value of screening for prostate cancer in the US?

被引：6

作者：

Albertsen, PC ^{[1
]}

机构：

[1] Univ Connecticut, Ctr Hlth, Dept Urol Surg, Farmington, CT 06030 USA

来源：

NATURE CLINICAL PRACTICE ONCOLOGY | 2005年 / 2卷 / 11期

关键词：

D O I：

10.1038/ncponc0348

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：536 / 537

页数：2

共 10 条

[1] 20-year outcomes following conservative management of clinically localized prostate cancer [J].

Albertsen, PC ;

Hanley, JA ;

Fine, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17) :2095-2101

[2] Radical prostatectomy versus watchful waiting in early prostate cancer [J].

Bill-Axelson, A ;

Holmberg, L ;

Ruutu, M ;

Häggman, M ;

Andersson, SO ;

Bratell, S ;

Spångberg, A ;

Busch, C ;

Nordling, S ;

Garmo, H ;

Palmgren, J ;

Adami, HO ;

Norlén, BJ ;

Johansson, JE .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (19) :1977-1984

[3] ADVANCES IN DIAGNOSTIC-IMAGING AND OVERESTIMATIONS OF DISEASE PREVALENCE AND THE BENEFITS OF THERAPY [J].

BLACK, WC ;

WELCH, HG .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (17) :1237-1243

[4] Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy [J].

D'Amico, AV ;

Chen, MH ;

Roehl, KA ;

Catalona, WJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (02) :125-135

[5] Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer [J].

Draisma, G ;

Boer, R ;

Otto, SJ ;

van der Cruijsen, IW ;

Damhuis, RAM ;

Schröder, FH ;

de Koning, HJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (12) :868-878

[6]

EASTHAM JA, 2004, JAMA-J AM MED ASSOC, V289, P2695

[7] Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy - A diagnosis that should not be made [J].

Epstein, JI .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (04) :477-478

[8] Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable [J].

Hugosson, J ;

Aus, G ;

Lilja, H ;

Lodding, P ;

Pihl, CG ;

Pileblad, E .

JOURNAL OF UROLOGY, 2003, 169 (05) :1720-1723

[9] The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years? [J].

Stamey, TA ;

Caldwell, M ;

McNeal, JE ;

Nolley, R ;

Hemenez, M ;

Downs, J .

JOURNAL OF UROLOGY, 2004, 172 (04) :1297-1301

[10] Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter [J].

Thompson, IM ;

Pauler, DK ;

Goodman, PJ ;

Tangen, CM ;

Lucia, MS ;

Parnes, HL ;

Minasian, LM ;

Ford, LG ;

Lippman, SM ;

Crawford, ED ;

Crowley, JJ ;

Coltman, CA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (22) :2239-2246

← 1 →